Abstract
A promising new TB drug cocrystallized with its mycobacterial target provides a platform for structure-based design that will improve TB drug development (Neres et al.).
MeSH terms
-
Antitubercular Agents / chemistry*
-
Antitubercular Agents / pharmacology*
-
Microbial Viability / drug effects*
-
Mycobacterium tuberculosis / drug effects*
-
Thiazines / chemistry*
-
Thiazines / pharmacology*
Substances
-
Antitubercular Agents
-
Thiazines